News and Updates

quay_takes_lead_in_production_of_live_medicines_in_exciting_microbiome_therapeutics_space.png

Quay takes lead in production of “live” medicines in exciting Microbiome therapeutics space

05/10/2018
Pharmaceutical outsourcing specialist Quay Pharma is continuing to invest in its pioneering work in live biotherapeutics with the establishment of specialist GMP suites at its facility in Deeside,...
ct.gov-nlm-nih-logo.png

Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients

29/08/2018
Accelerated AC regimen-Doxorubicin 60 mg/m2,Cyclophosphamide 600 mg/m2 on day 1 & day 14 of each cycle along with G-CSF support for up to 4 cycles, followed by Paclitaxel 175 mg/m2 in the next 4...
denarase

Use of DENARASE® for tomorrow´s industry

08/08/2018
Background & Motivation to use DENARASE® The removal of nucleic acids from biological samples is a necessary step for applications in Red Biotechnology and Molecular Biology. Along the production...
denarase

DENARASE® | Upgrading the Endonuclease from Serratia marcesce

08/08/2018
>> Download the full article by clicking here << Appropriate handling and removal of nucleic acids is crucial for many applications in red biotechnology and molecular biology. Upon the...
artificial_intelligence

AI to reshape bioprocessing and drug discovery say experts

06/08/2018
Artificial intelligence (AI) will change biopharmaceutical discovery and manufacturing according to experts who say these data-rich processes are ideal for the application of computer-based learning...
Biopharmaceutical medicines article

Making a biomanufacturing team: challenges and strategies

23/07/2018
Making biopharmaceutical medicines is a highly technical process that requires a diverse range of handling, production and process skills. Rapid growth of the sector, combined with the shortage of...
biopharma outsourcing

CDMO revenues reflect bio outsourcing surge says expert

09/07/2018
Biopharmaceutical outsourcing has increased markedly in recent years with a greater volume of work previously kept in-house being handed over to third party contractors. The trend is evident in the...
bioprocessing tech

Pipelines, economics and IP: How bioprocessing tech firms assess markets

09/07/2018
Epidemiology is a core skill for biopharmaceutical companies. Being able to identify an area of unmet medical need helps guide R&D strategy and, ultimately, is what shapes drug pipelines. It is...
bioLIVE Whitepaper - Opposite attract

bioLIVE Whitepaper | Opposites attract. Blurring the lines between small and large molecule manufacturing

25/06/2018
bioLIVE's latest whitepaper collects finding from a panel of experts that have identified potential applications of small molecule expertise that should be applied to the biologics industry . Click...
gene_therapy

Gene therapy: A complex and fast-evolving manufacturing challenge

23/05/2018
Gene therapies could revolutionise the treatment of inherited diseases but firms hoping to follow Luxturna to market must remember that, from a manufacturing perspective, the field is still in its...
Pipette

CDMOs primed for biologics boom

23/05/2018
Outsourcing took longer to catch on in the biopharma sector than in the small molecule drug industry. Initially, biologic developers did production in-house with only activities like fill/finish...
bioLIVE breakfast session, people attending a meeting

Interview with Mary Lynn Bercik of NIBRT on the bioLIVE breakfast session at CPhI North America

25/04/2018
At CPhI North America, we are hosting a breakfast meeting to provide a sneak peek of next year’s all-new event: BioLive . We caught up with one of our expert speakers, Mary Lynn Bercik of Johnson...

Pages